Full Episode
Friday, Jul 10
PBS NewsHour
  • Episodes
  • Podcasts
  • Newsletters
  • The Latest
  • Politics
    Politics
    • Brooks and Capehart
    • Politics Monday
    • Supreme Court
  • Arts
    Arts
    • CANVAS
    • Poetry
    • Now Read This
  • Nation
    Nation
    • America at a Crossroads
    • Supreme Court
    • Race Matters
    • Essays
    • Brief But Spectacular
  • World
    World
    • Agents for Change
    • Compass Points
  • Economy
    Economy
    • Making Sen$e
    • Paul Solman
  • Science
    Science
    • The Leading Edge
    • ScienceScope
    • Basic Research
    • Innovation and Invention
  • Health
    Health
    • Horizons
    • Long-Term Care
  • Education
    Education
    • Teachers' Lounge
    • Student Reporting Labs
  • For Teachers
    Education
    • Newshour Classroom
  • About
    • Feedback
    • Funders
    • Support
    • Jobs

Educate your inbox

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

Form error message goes here.

Thank you. Please check your inbox to confirm.

Nation
PBS News

Get news alerts from PBS News

Turn on desktop notifications?

weight loss drugs

  • Full Episodes
  • Podcasts
  • Newsletters
  • Live
glp1glp1

Health Jul 09

Some Medicare beneficiaries eligible for weight loss drug discounts

By William Brangham, Andrew Merlis, Solveig Rennan

Health Jun 19

glp1andcancer
Watch 7:40
Research shows weight-loss drugs may also reduce cancer risk

A growing body of research suggests popular weight-loss drugs like Ozempic and Wegovy may also help treat or prevent certain cancers. It’s the latest unexpected benefit to be associated with GLP-1s, which are now taken by one-in-eight American adults. William…

By William Brangham, Jackson Hudgins

Health Apr 01

Eli Lilly-Weight-Loss-Pill
FDA grants speedy approval to Eli Lilly's weight-loss pill for obesity

The Food and Drug Administration's decision Wednesday means patients in the United States will soon have access to a second daily oral medication to treat obesity and weight-related issues.

By JoNel Aleccia, Associated Press

Health Nov 06

U.S. President Trump makes an announcement from the Oval Office, at the White House in Washington
Watch 7:10
The potential impact of lowering the cost of weight loss drugs

Millions of Americans will soon have direct access to popular weight-loss drugs at far lower prices than they pay now. That’s due to a deal announced between President Trump and pharmaceutical giants Eli Lilly and Novo Nordisk. William Brangham discussed…

By William Brangham, Jackson Hudgins, Jenna Bloom

Health Jun 29

weightlossdrugs
Watch 6:15
New book by former FDA head explores the science behind GLP-1 weight loss drugs

According to the CDC, 1 in 5 American adults is living with obesity. In recent years, many have turned to weight loss drugs containing GLP-1, a hormone that slows digestion and helps with sustained weight loss. In a new book,…

By Ali Rogin, Zoie Lambert

Apr 14

Pfizer abandons potential obesity treatment pill

By Tom Murphy, Associated Press

The drugmaker said Tuesday that it would stop studying danuglipron after a participant in one of its trials experienced a possible drug-induced liver injury that ended once the person stopped taking the treatment.

Continue reading

Jan 02

Watch 6:00
As weight loss drug demand soars, physician outlines effectiveness and potential downsides

By William Brangham, Jackson Hudgins, Hamada Hanoura

For weight loss drugs like Ozempic and Wegovy, 2024 was a big year. More patients are relying on them to manage their weight, treat diabetes, or prevent heart attacks and strokes. And while they are highly effective, they also come…

Continue watching

Oct 26

Watch 8:07
Why more doctors are treating children and adolescents with weight loss drugs

By Ali Rogin, Satvi Sunkara

Physicians are increasingly using weight loss drugs to treat obesity, diabetes and other chronic conditions in young patients. In the last three years, the number of people between the ages of 12 and 25 using drugs like Wegovy and Ozempic…

Continue watching

Sep 24

Watch 3:57
Lawmakers challenge drug company CEO over steep prices for Ozempic and Wegovy

By William Brangham, Courtney Norris, Ryan Connelly Holmes

Ozempic and Wegovy are some of the most popular drugs in the country, driven by their remarkable success in treating diabetes and obesity. But the drugs are extremely expensive, and the drugmaker’s CEO appeared on Capitol Hill Tuesday to face…

Continue watching

Jun 17

Watch 8:38
The many ways new weight loss drugs could transform the economy

By Catherine Rampell, Diane Lincoln Estes

Last year, Americans spent over $50 billion on weight loss drugs like Ozempic and Wegovy. Their popularity, and their price, are having effects throughout the economy. PBS News Hour special correspondent and Washington Post columnist Catherine Rampell reports.

Continue watching

Jump to the First Page Previous Page
1 2
Next Page Jump to the Last Page

Support Provided By: Learn more

Invest in the future of PBS News. Help us start the fiscal year strong. Give Now.

Educate your inbox

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

Form error message goes here.

Thank you. Please check your inbox to confirm.

Full Episode
Friday, Jul 10
  • BNSF Railway
  • Consumer Cellular
  • Raymond James
  • Friends of the News Hour
PBS News

© 1996 - 2026 NewsHour Productions LLC. All Rights Reserved.

PBS is a 501(c)(3) not-for-profit organization.

Sections

  • The Latest
  • Politics
  • Arts
  • Nation
  • World
  • Economy
  • Science
  • Health
  • Education

About

  • About Us
  • TV Schedule
  • Press
  • Feedback
  • Funders
  • Support
  • Newsletters
  • Podcasts
  • Jobs
  • Privacy
  • Terms of Use

Stay Connected

  • Facebook
  • YouTube
  • Instagram
  • X
  • TikTok
  • Threads
  • RSS

Subscribe to Here's the Deal with Lisa Desjardins

Form error message goes here.

Thank you. Please check your inbox to confirm.

Support our journalism

Support for News Hour Provided By

  • BNSF Railway
  • Consumer Cellular
  • Raymond James
  • Viewers Like You